Neurology ReviewsDuloxetine Bottles Recalled by FDA Because of Potential CarcinogenOctober 28, 2024Pain
Neurology ReviewsFDA Approves First Targeted Therapy for Gliomas With IDH MutationsAugust 7, 2024Neuro-oncology
Neurology ReviewsFDA Expands Repotrectinib Label to All NTRK Gene Fusion+ Solid TumorsJune 14, 2024Neuro-oncology
Neurology ReviewsFDA Removes Harmful Chemicals From Food PackagingMarch 1, 2024Mixed TopicsPediatricsBusiness of MedicineNeuro-oncologyAlzheimer's & CognitionNeurodevelopmental Disorders
Neurology ReviewsFDA warns of potentially lethal reaction to seizure medsNovember 29, 2023Epilepsy & SeizuresMixed Topics
Clinical Neurology NewsFDA to step up oversight of cosmetics, assess ‘forever chemicals’August 31, 2023Mixed Topics
Neurology ReviewsMore children missing developmental milestones: SurveyJuly 14, 2023PediatricsNeurodevelopmental Disorders
Neurology ReviewsFDA clears new biomarker assays for early Alzheimer’s detectionJune 27, 2023Alzheimer's & Cognition
Neurology ReviewsFDA panel unanimously endorses lecanemab for Alzheimer’sJune 12, 2023Alzheimer's & Cognition
Neurology ReviewsNew report says suicide rates rising among young Black peopleFebruary 14, 2023Diversity in MedicineMixed TopicsCOVID-19 Updates
Neurology ReviewsAlzheimer’s Association to CMS: Ditch restraints on amyloid drugsDecember 22, 2022Alzheimer's & CognitionBusiness of Medicine
